Development of a glycopolymer for the therapy of multifocal motor neuropathy

• Unité de recherche: INNOSUISSE
• Numéro de projet: 27163.1 PFLS-LS
• Titre du projet anglais: Development of a glycopolymer for the therapy of multifocal motor neuropathy

Description succincte (Allemand)

Entwicklung eines Glykopolymers für die Therapie der Multifokalen Motorischen Neuropathie

Description succincte (Anglais)

Development of a glycopolymer for the therapy of multifocal motor neuropathy

Résumé des résultats (Abstract) (Allemand)

Multifocal motor neuropahty (MMN) is a disabling autoimmune neuropathy caused by pathogenic anti-GM1 IgM antibodies. Current treatment options are non-selective and lack long-term efficacy. The project aims at a personalized therapy with a glycopolymer that selectively sequesters anti-GM1 IgM.